106 related articles for article (PubMed ID: 9625438)
1. ONO-4007 induces specific anti-tumor immunity mediated by tumor necrosis factor-alpha.
Matsushita K; Kobayashi M; Totsuka Y; Hosokawa M
Anticancer Drugs; 1998 Mar; 9(3):273-82. PubMed ID: 9625438
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of a new synthetic lipid A analog, ONO-4007, on rat hepatoma KDH-8 depend on tumor necrosis factor-sensitivity of the tumor cells.
Kuramitsu Y; Matsushita K; Ohiro Y; Obara M; Kobayashi M; Hosokawa M
Anticancer Drugs; 1997 Oct; 8(9):898-901. PubMed ID: 9402318
[TBL] [Abstract][Full Text] [Related]
3. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.
Kuramitsu Y; Nishibe M; Ohiro Y; Matsushita K; Yuan L; Obara M; Kobayashi M; Hosokawa M
Anticancer Drugs; 1997 Jun; 8(5):500-8. PubMed ID: 9215614
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of locally enhanced production of tumor necrosis factor-alpha in tumor tissues by the administration of a new synthetic lipid A analog, ONO-4007, in hepatoma-bearing rats.
Kuramitsu Y; Ohiro Y; Matsushita K; Obara M; Kobayashi M; Hosokawa M
Anticancer Drugs; 1997 Oct; 8(9):886-93. PubMed ID: 9402316
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral tumor necrosis factor induction and tumor growth suppression by ONO-4007, a low-toxicity lipid A analog.
Matsumoto N; Oida H; Aze Y; Akimoto A; Fujita T
Anticancer Res; 1998; 18(6A):4283-9. PubMed ID: 9891479
[TBL] [Abstract][Full Text] [Related]
6. ONO-4007, a synthetic lipid A analog, induces Th1-type immune response in tumor eradication and restores nitric oxide production by peritoneal macrophages.
Matsushita K; Kuramitsu Y; Ohiro Y; Kobayashi I; Watanabe T; Kobayashi M; Hosokawa M
Int J Oncol; 2003 Aug; 23(2):489-93. PubMed ID: 12851700
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed proteins in tumour necrosis factor-alpha-resistant and -sensitive rat hepatoma cells.
Kuramitsu Y; Zhang X; Wang Y; Nakamura K
Anticancer Res; 2011 Jun; 31(6):2059-63. PubMed ID: 21737623
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumor necrosis factor in a murine tumor by systemic administration of a novel synthetic lipid A analogue, ONO-4007.
Ueda H; Yamazaki M
J Immunother; 1997 Jan; 20(1):65-9. PubMed ID: 9101415
[TBL] [Abstract][Full Text] [Related]
9. Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin.
Yuan L; Kuramitsu Y; Li Y; Kobayashi M; Hosokawa M
Cancer Immunol Immunother; 1995 Dec; 41(6):355-62. PubMed ID: 8635193
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effect of a new synthetic lipid A analog (ONO-4007) on a tumor implanted at different sites in rats.
Mizushima Y; Sassa K; Fujishita T; Oosaki R; Kobayashi M
J Immunother; 1999 Sep; 22(5):401-6. PubMed ID: 10546155
[TBL] [Abstract][Full Text] [Related]
11. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
12. Synthetic lipid A produces antitumor effect in a hamster pancreatic carcinoma model through production of tumor necrosis factor from activated macrophages.
Morita S; Yamamoto M; Kamigaki T; Saitoh Y
Kobe J Med Sci; 1996 Aug; 42(4):219-31. PubMed ID: 9023454
[TBL] [Abstract][Full Text] [Related]
13. Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cells.
Yuan L; Kobayashi M; Kuramitsu Y; Li Y; Matsushita K; Hosokawa M
Cancer Immunol Immunother; 1997 Oct; 45(2):71-6. PubMed ID: 9390197
[TBL] [Abstract][Full Text] [Related]
14. Restoration of immune responses in tumor-bearing mice by ONO-4007, an antitumor lipid A derivative.
Matsumoto N; Aze Y; Akimoto A; Fujita T
Immunopharmacology; 1997 Apr; 36(1):69-78. PubMed ID: 9129998
[TBL] [Abstract][Full Text] [Related]
15. Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects.
Yang D; Satoh M; Ueda H; Tsukagoshi S; Yamazaki M
Cancer Immunol Immunother; 1994 May; 38(5):287-93. PubMed ID: 8162610
[TBL] [Abstract][Full Text] [Related]
16. Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity.
Satoh M; Tsurumaki K; Kagehara H; Yamazaki M
Cancer Immunol Immunother; 2002 Feb; 50(12):653-62. PubMed ID: 11862417
[TBL] [Abstract][Full Text] [Related]
17. ONO-4007, a new synthetic lipid A derivative, induces differentiation of rat myelomonocytic leukemia cells in vitro and in vivo.
Kobayashi M; Nagayasu H; Hamada J; Takeichi N; Hosokawa M
Exp Hematol; 1994 May; 22(5):454-9. PubMed ID: 8174676
[TBL] [Abstract][Full Text] [Related]
18. A signaling pathway by a new synthetic lipid A analog, ONO-4007, in RAW264.7 cells.
Saito Y; Kuramitsu Y; Arai H; Kato Y; Fujimoto M; Ita M; Hayatsu Y; Shinozaki F; Nakamura K
Anticancer Drugs; 2002 Nov; 13(10):1069-75. PubMed ID: 12439341
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of phosphatidylethanol-amine-binding protein in rat hepatoma cell lines: analyses of tumor necrosis factor-alpha-resistant cKDH-8/11 and -sensitive KDH-8/YK cells by two-dimensional gel electrophoresis.
Kuramitsu Y; Fujimoto M; Tanaka T; Ohata J; Nakamura K
Electrophoresis; 2000 Feb; 21(3):660-4. PubMed ID: 10726774
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G
Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
